Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Syndax Pharmaceuticals Inc (SNDX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/10/2023 |
SC 13G
| WELLINGTON MANAGEMENT GROUP LLP reports a 11.7% stake in Syndax Pharmaceuticals Inc |
| 02/14/2022 |
SC 13G
| Nantahala Capital Management, LLC reports a 5.8% stake in Syndax Pharmaceuticals, Inc. |
| 12/23/2021 |
SC 13G
| Frazier Life Sciences Public Fund, L.P. reports a 5.6% stake in Syndax Pharmaceuticals, Inc. |
| 05/10/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/02/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 11/04/2020 |
SC 13G
| Avidity Partners Management LP reports a 6.7% stake in Syndax Pharmaceuticals, Inc. |
| 05/11/2020 |
SC 13G
| Boxer Capital, LLC reports a 7.6% stake in Syndax Pharmaceuticals, Inc. |
| 10/09/2019 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 04/08/2019 |
SC 13G
| ADAGE CAPITAL PARTNERS GP, L.L.C. reports a 5.7% stake in Syndax Pharmaceuticals, Inc. |
| 02/07/2019 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 11/29/2018 |
SC 13G
| 683 Capital Management, LLC reports a 5% stake in Syndax Pharmaceuticals, Inc. |
| 11/13/2017 |
SC 13G
| BIOTECHNOLOGY VALUE FUND L P reports a 8.3% stake in Syndax Pharmaceuticals, Inc. |
| 02/09/2017 |
SC 13G
| Syndax Pharmaceuticals Inc reports a 11.9% stake in Syndax Pharmaceuticals, Inc. |
| 01/30/2017 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
| 01/09/2017 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
| 09/12/2016 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
|
|